At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 267 enrolled
Drug / intervention
DFD06 Cream +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days
In Brief
A Phase 3 clinical trial evaluating DFD06 Cream and Vehicle Cream for Psoriasis. Completed, enrolled 267 participants across 30 sites.
Detailed Summary
This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedDec 2015
Primary CompletionJul 2016
TodayJul 2026
First PostedDec 18, 2015
Enrollment StartDec 1, 2015
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.5 years ago
Interventions
DFD06 Creamdrug
Twice daily topical application for 14 days.
Vehicle Creamdrug
Twice daily topical application for 14 days.